echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Tyrvaya nasal spray for the treatment of dry eye is approved by the FDA for marketing

    Tyrvaya nasal spray for the treatment of dry eye is approved by the FDA for marketing

    • Last Update: 2021-11-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On October 18, 2021, Oyster Point Pharma announced that the US FDA has approved Tyrvaya (varenicline) nasal spray for the treatment of dry eye


    Dry eye is a chronic disease that can cause persistent stinging, burning sensation, sensitivity to light, blurred vision, and eye fatigue


    Unlike other eye drops, Tyrvaya nasal spray is a highly selective cholinergic agonist, delivered as an aqueous nasal spray twice a day


    Image source: Oyster Point's official website

    This approval is based on positive data from a series of clinical trials that evaluated Tyrvaya nasal spray in more than 1,000 patients with mild/moderate/severe dry eye


    Reference materials:

    [1] Oyster Point Pharma Announces FDA Approval of Tyrvaya™ (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease.


    (The original text has been deleted)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.